Objectives: Caffeine is a widely consumed pharmacologically active product. In the present study, we focused on characterizing immunomodulatory effects of caffeine on peripheral blood mononuclear cells (PMBCs).
INTRODUCTION
Systemic autoimmune diseases result from dysregulation of the immune response which usually causes antigen-presenting cells to trigger autoreactive lymphocytes, and are often associated with chronic inflammation involving numerous cytokines. Persistent T cell activation and the production of inflammatory cytokines lead to tissue damage. The etiopathogenesis of autoimmune diseases is not completely understood. Many different combinations of genetic and environmental factors are thought to promote the development and progression of autoimmunity.
The inheritance of epigenetic susceptibility loci can cause diversity in disease prevalence and severity between different ethnic and geographical populations [1, 2] .
Previous studies have shown that epigenetic factors, including DNA methylation changes, are involved in the pathogenesis of autoimmune diseases including rheumatoid arthritis and systemic lupus erythematosus [3] . Being a source of external factors responsible for some epigenetic changes, diet has been shown to affect the severity of autoimmune diseases in animal models [4] . Moreover, the study of gene-environment interactions might help clarify the pathogenic consequences of both genetic and environmental influences in autoimmunity.
Caffeine is one of the most widely consumed pharmacologically active products in the world. Hence, its pharmacological properties, physiological effects, and potential treatment doses have been a subject of interest for years. Even though chocolates and cocoa containing foods store some amount of caffeine, the main source of caffeine in daily life is coffee or other caffeinated beverages such as energy drinks, tea, and carbonated soft drinks [5] . Caffeine has several effects on the body, including central nervous system stimulation. In addition, caffeine is a member of the methylxanthine family and has been used in neonatal intensive care units to treat apnea of prematurity. It has been studied for its effects on different diseases and was recently shown to reduce the incidence of bronchopulmonary dysplasia in neonates [6] . Previous studies suggested that caffeine is associated with reduced risk for some cancer types, chronic liver disease, Parkinson's disease, Alzheimer's disease, and diabetes [7, 8] .
Studies using animal models suggest that caffeine has modulatory effects on elevated serum aminotransferase enzymes and the migration of inflammatory cells [8] . It also decreases serum inflammatory cytokine levels by suppressing their mRNA expression levels, suggesting an anti-inflammatory effect of caffeine [7, 9] .
When studied with rats, chronic treatment with caffeine (10 and 30 mg/kg) has been found to ameliorate experimental autoimmune encephalomyelitis [10] .
Methylxanthines, which include pentoxifylline and caffeine as members, mediate their effects by inhibiting cAMP-specific phosphodiesterase activity, thus, increasing levels of intracellular cAMP which has immunomodulatory effects on lymphocytes and monocytes/macrophages [11] . Cross-sectional studies have reported an association between higher coffee consumption and lower plasma concentrations of several markers of inflammation and endothelial dysfunction [12] .
In this study, we focused on examining the immunomodulatory effects of caffeine using PBMCs obtained from healthy individuals. Our purpose was to evaluate the effect of caffeine on genes and pathways related to autoimmunity.
RESULTS
To characterize the effect of caffeine on gene expression patterns in human PBMCs, we first used RNA sequencing data publically available from a recent study that examined gene expression profiles in multiple cell types, including primary human PBMCs, in response to a large number of environmental factors for the purpose of understanding gene-environment interactions [13] . Gene expression profiles in PBMCs from 3 healthy individuals stimulated with PHA (2.5ug/ml) with and without caffeine treatment (1.16 mM for 6 hours) were extracted. Differential expression was determined using a fold difference ≥ 1.5 and a p value ≤ 0.05 after correction for multiple testing using false discovery rate. We identified 3,437 upregulated and 2,811 downregulated genes with caffeine treatment (Supplementary Tables 1 and 2) .
Gene ontology and pathway analysis revealed far more significant functional enrichment categories in genes downregulated compared to genes upregulated with caffeine treatment. Downregulated genes are clearly enriched in immune-related categories such as "cytokine activity" (GO:0005125) and "immune response" (GO:0006955). Likewise, when we examined disease enrichment patterns in gene downregulated with caffeine treatment we noticed downregulation of genes involved in multiple autoimmune diseases including systemic lupus erythematosus and rheumatoid arthritis with caffeine treatment (Table 1) . Gene ontology analysis in upregulated genes pointed out "phosphotransferase activity" (GO:0016773) and "kinase activity" (GO:0016301), among other enriched gene ontologies ( Table 2) .
As we detected a strong evidence for downregulating pathways involved in many immune-related genes with caffeine treatment, we performed validation experiments in a selected number of relevant downregulated genes to examine the dose-dependent effect of caffeine concentrations. We focused on the potential downregulatory effects of caffeine on autoimmunity and related inflammatory pathways. We selected genes within the most downregulated functional categories We observed significant downregulation of STAT1, TNF, and PPARG with caffeine treatment in PBMCs ( Table 3) . A dose-dependent reduction in the expression STAT1 was observed with intermediate (p=0.0384) and high (p=0.0001) caffeine concentrations. Expression levels of TNF and PPARG were significantly reduced at all caffeine concentrations, with a dose-response effect also observed (Figure 1) . In contrast to STAT1, mRNA expression levels of TNF and PPARG were also suppressed at low caffeine concentration (0.019 mM), which is approximately equivalent to the serum caffeine concentration after administration of one cup of coffee.
Because of enrichment of cytokine genes and cytokine activity in functional enrichment analysis of genes downregulated with caffeine treatment, we measured cytokine production levels in cell culture media from PBMCs treated with and without caffeine. We observed significant reduction in the production of multiple inflammatory cytokines, validating gene expression patterns we observed. IL-8 levels were significantly reduced with any caffeine treatment, in a dose-dependent manner.
Significant reduction in the levels of IL-6, IFNγ, TNF, MCP-1 and IL-10 was also observed at medium and high caffeine concentrations (Figure 2, Table 4 ).
DISCUSSION
Many autoimmune diseases accompany chronic inflammatory state which involves multiple organs and systems. According to National Institute of Allergy and Infectious Diseases, there are more than 80 autoimmune diseases ranging from mild to severe multiorgan involving forms and affecting patients' quality of life and mental status [14] . In severe forms, they can be related to increased mortality by causing end-organ failure.
Heritable genetic alterations, immune system abnormalities, and environmental elements contribute to the development and progression of many autoimmune diseases [15] . Indeed, environmental factors can influence disease susceptibility by means of epigenetics mechanisms such as DNA methylation and histone modification processes. In this regard, it is not unexpected that diet might have an important role. Recent studies have demonstrated the influence of dietary factors on autoantibody levels and disease severity in mouse models of autoimmunity [4, 16] .
The present study questioned and demonstrated the in vitro downregulatory effects of a commonly consumed product, caffeine, on inflammation and autoimmunity related genes, pathways, and inflammatory cytokine levels.
TNF, being an important inflammatory cytokine in many immune-mediated diseases, is target of several therapeutics [17] . Previous studies indicated that TNF is involved in the release of other inflammatory cytokines such as IL-1 and IL-6 [18] .
We demonstrate suppression of TNF production both at the mRNA and protein levels with low to intermediate caffeine concentrations. Indeed, caffeine concentrations corresponding to serum levels after the consumption of one cup of coffee was associated with significant suppression of TNF production in PBMCs.
Cytokines are known to have a key role in autoimmune diseases, and several pro-inflammatory cytokines were reduced with caffeine treatment in our study. IL-6 and IL-10 which are both significantly elevated in the serum with increased disease activity in lupus patients can be downregulated with caffeine. Indeed, IL-10 is In summary, we demonstrate that caffeine, even with low concentrations, can suppress gene expression of pro-inflammatory genes and cytokines that play key roles in autoimmune diseases. Further work to characterize the mechanisms involved in the anti-inflammatory effects observed and whether caffeine supplementation might have beneficial effects in patients with autoimmune diseases are worthy of investigation.
METHODS

RNA sequencing data
RNA sequencing data derived from PMBCs with and without treatment with caffeine were extracted from a publically available dataset. These data were generated using PBMCs isolated from 3 healthy individuals. PBMCs were activated with PHA and then treated with or without caffeine for 6 hours at a concentration of 1.16 mM prior to RNA expression and sequencing [13] .
Isolating PBMCs and cell culture
PBMCs were isolated using density gradient centrifugation (Ficoll) from buffy coats isolated from whole blood of 11 healthy blood donors and stored in liquid nitrogen.
PBMCs were thawed and suspended in warm RPMI (RPMI+L-glutamine+10% FBS)/benzonase. Following resuspension, cells were centrifuged at 300xg for 10 minutes, suspended, then centrifuged again at 100xg for 10 minutes. PBMCs were then cultured in RPMI without benzonase and transferred to 6-well plates to rest overnight at 37 degrees Celsius with 5.0% CO 2 . Cells were then centrifuged at 300xg for 10 minutes, then plated at 1×10 6 cells/mL in RPMI with L-Glutamine and 0.1% charcoal-stripped FBS (1-2 million cells in 1ml media in a 12-well plate). Cells were activated with PHA (2.5µg/mL) and incubated with or without caffeine for 6
hours. Three different concentration of caffeine were used: Low (0.019 mM), 
Bioinformatics analysis
Functional enrichment analysis of genes upregulated and downregulated with caffeine treatment was performed using ToppGene to identify Gene Ontology 
Statistical analysis
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